Novo Nordisk spotlights star diabetes drugs in massive TV ad campaigns

In 2021, pharmaceutical firm Novo Nordisk spent enormous sums of money on advertising diabetes drugs Ozempic and Rybelsus. (Corrected)

Photo: Tidsvilde Stine/Ritzau Scanpix

(Corrected at 9:25 am, January 25: An earlier version of the article did not contain sales figures in the correct currency for Rybelsus and Ozempic.)

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs